Civeo Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Civeo in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Civeo stock.
View analyst ratings for Civeo or view top-rated stocks.

Wall Street analysts have given Civeo a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Civeo wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Civeo is scheduled to release its next quarterly earnings announcement on Wednesday, October 27th 2021.
View our earnings forecast for Civeo.

Civeo Co. (NYSE:CVEO) released its quarterly earnings data on Thursday, July, 29th. The business services provider reported $0.52 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.17) by $0.69. The business services provider had revenue of $154.18 million for the quarter, compared to the consensus estimate of $136.55 million. Civeo had a positive trailing twelve-month return on equity of 0.66% and a negative net margin of 0.77%.
View Civeo's earnings history.

Civeo's stock was trading at $9.0372 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CVEO stock has increased by 143.8% and is now trading at $22.03.
View which stocks have been most impacted by COVID-19.

Civeo's stock reverse split before market open on Friday, November 20th 2020. The 1-12 reverse split was announced on Monday, November 9th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 19th 2020. An investor that had 100 shares of Civeo stock prior to the reverse split would have 8 shares after the split.

Civeo issued an update on its FY 2021 earnings guidance on Friday, August, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $555 million-$580 million, compared to the consensus revenue estimate of $554.96 million.

1 analysts have issued 12-month price objectives for Civeo's shares. Their forecasts range from $2.50 to $2.50. On average, they expect Civeo's stock price to reach $2.50 in the next twelve months. This suggests that the stock has a possible downside of 88.7%.
View analysts' price targets for Civeo or view top-rated stocks among Wall Street analysts.

15 employees have rated Civeo CEO Bradley J. Dodson on Glassdoor.com. Bradley J. Dodson has an approval rating of 75% among Civeo's employees.

Some companies that are related to Civeo include H.I.S. (HISJF), The RealReal (REAL), Playa Hotels & Resorts (PLYA), Monarch Casino & Resort (MCRI), F45 Training (FXLV), Hong Kong Television Network (HKTVY), Flight Centre Travel Group (FGETF), Accel Entertainment (ACEL), American Woodmark (AMWD), DouYu International (DOYU), Johnson Outdoors (JOUT), Smith & Wesson Brands (SWBI), Austerlitz Acquisition Co. I (AUS), IMAX (IMAX) and The Honest (HNST).
View all of CVEO's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Civeo investors own include Novavax (NVAX), Co-Diagnostics (CODX), Livongo Health (LVGO), NVIDIA (NVDA), Alto Ingredients (PEIX), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Maxar Technologies (MAXR), Marvell Technology (MRVL) and The Boeing (BA).

Civeo trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVEO."

Civeo's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (5.44%), Dimensional Fund Advisors LP (1.76%), TCW Group Inc. (1.48%), Invenomic Capital Management LP (1.17%), Balyasny Asset Management LLC (1.02%) and Bank of Montreal Can (0.60%). Company insiders that own Civeo stock include Allan Schoening, Bradley J Dodson, Lance Torgerson, Martin Lambert and Peter Mccann.
View institutional ownership trends for Civeo.

CVEO stock was sold by a variety of institutional investors in the last quarter, including Balyasny Asset Management LLC, Renaissance Technologies LLC, Connor Clark & Lunn Investment Management Ltd., Group One Trading L.P., and PNC Financial Services Group Inc.. Company insiders that have sold Civeo company stock in the last year include Allan Schoening, Bradley J Dodson, Lance Torgerson, and Peter Mccann.
View insider buying and selling activity for Civeo or view top insider-selling stocks.

CVEO stock was bought by a variety of institutional investors in the last quarter, including TCW Group Inc., Bridgeway Capital Management LLC, Invenomic Capital Management LP, Diametric Capital LP, Morgan Stanley, Morgan Stanley, Bank of Montreal Can, and Dimensional Fund Advisors LP. Company insiders that have bought Civeo stock in the last two years include Bradley J Dodson, and Martin Lambert.
View insider buying and selling activity for Civeo or or view top insider-buying stocks.

Shares of CVEO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CVEO stock can currently be purchased for approximately $22.03.

Civeo has a market capitalization of $315.38 million and generates $529.73 million in revenue each year. The business services provider earns $-134,250,000.00 in net income (profit) each year or $0.89 on an earnings per share basis.

Civeo employs 2,000 workers across the globe.

The official website for Civeo is www.civeo.com.

Civeo is headquartered at THREE ALLEN CENTER 333 CLAY STREET SUITE 4980, HOUSTON TX, 77002.

Civeo's mailing address is THREE ALLEN CENTER 333 CLAY STREET SUITE 4980, HOUSTON TX, 77002. The business services provider can be reached via phone at (713) 510-2400 or via email at [email protected].